Fluoroquinolone resistance mutations in the parC, parE, and gyrA genes of clinical isolates of viridans group streptococci - Wikidata - awgldk - TriplyDB

Fluoroquinolone resistance mutations in the parC, parE, and gyrA genes of clinical isolates of viridans group streptococci

Fluoroquinolone resistance mutations in the parC, parE, and gyrA genes of clinical isolates of viridans group streptococci

http://www.wikidata.org/entity/Q33700561

about

Dissemination of Antimicrobial Resistance in Microbial Ecosystems through Horizontal Gene Transfer New species genetic approach to identify strains of mitis group streptococci that are donors of rifampin resistance to Streptococcus pneumoniae.Identification of ciprofloxacin-resistant Campylobacter jejuni by use of a fluorogenic PCR assay.In vitro activities of fluoroquinolones against antibiotic-resistant blood culture isolates of viridans group streptococci from across Canada.Fluoroquinolone resistance associated with target mutations and active efflux in oropharyngeal colonizing isolates of viridans group streptococci.Mefloquine and new related compounds target the F(0) complex of the F(0)F(1) H(+)-ATPase of Streptococcus pneumoniae.Extent of horizontal gene transfer in evolution of Streptococci of the salivarius group Viridans group streptococci are donors in horizontal transfer of topoisomerase IV genes to Streptococcus pneumoniae First characterization of fluoroquinolone resistance in Streptococcus suis.Fluoroquinolone resistance in penicillin-resistant Streptococcus pneumoniae clones, Spain.Streptococcus mutans clonal variation revealed by multilocus sequence typing.CovRS-Regulated Transcriptome Analysis of a Hypervirulent M23 Strain of Group A Streptococcus pyogenes Provides New Insights into Virulence Determinants.Genetic characterization of optochin-susceptible viridans group streptococci.Emergence of fluoroquinolone resistance in group B streptococcal isolates in Taiwan.E. coli Group 1 Capsular Polysaccharide Exportation Nanomachinary as a Plausible Antivirulence Target in the Perspective of Emerging Antimicrobial Resistance.Drug efflux and parC mutations are involved in fluoroquinolone resistance in viridans group streptococci.Horizontal transfer of parC and gyrA in fluoroquinolone-resistant clinical isolates of Streptococcus pneumoniae.Interspecies recombination contributes minimally to fluoroquinolone resistance in Streptococcus pneumoniae Mosaic genes and mosaic chromosomes: intra- and interspecies genomic variation of Streptococcus pneumoniae.Fluoroquinolone-resistant pneumococci: dynamics of serotypes and clones in Spain in 2012 compared with those from 2002 and 2006.Genetic characterization of fluoroquinolone-resistant Streptococcus pneumoniae strains isolated during ciprofloxacin therapy from a patient with bronchiectasis High-efficiency generation of antibiotic-resistant strains of Streptococcus pneumoniae by PCR and transformation.Complete Genome Sequence of Streptococcus mitis Strain SVGS_061 Isolated from a Neutropenic Patient with Viridans Group Streptococcal Shock Syndrome.Mutations in topoisomerase genes of fluoroquinolone-resistant salmonellae in Hong Kong.Fluoroquinolone resistance in atypical pneumococci and oral streptococci: evidence of horizontal gene transfer of fluoroquinolone resistance determinants from Streptococcus pneumoniae.Clinical Isolates of the Spain14-5 clone of Streptococcus pneumoniae carry a recombinant rpoB gene.Levofloxacin-resistant Streptococcus pneumoniae: second look.Fitness of Streptococcus pneumoniae fluoroquinolone-resistant strains with topoisomerase IV recombinant genes.Changes in fluoroquinolone-resistant Streptococcus pneumoniae after 7-valent conjugate vaccination, Spain.

P2860

Q26765870-E309E64A-36A7-45B9-AFD5-E221A64911BB Q33735606-2E03552F-21CB-4EED-AD5F-2E05868C0EA6 Q33970184-E8315116-389C-4C04-B53B-52D9281BA78B Q33977709-57799C0C-2EC6-4819-A2B5-A2A669F9C3C3 Q33980313-036F05D6-4223-4F80-8C92-470F6CDBB3DF Q34109476-3DDFAFCF-F211-43EB-9985-FA8D59D8ED4B Q34572328-7D3085C3-DA7D-4C86-942F-7C540BCE3E52 Q35102420-A1A5E983-3DFF-4FDF-B006-3C66C017761E Q35636018-D8429005-AAEA-4D4E-B899-8009A3AAAB95 Q35880792-14DEFCF8-D98D-49BC-B399-9F51A9B26BAB Q35947522-8B11A310-B1F6-4BFE-9C7C-B4392B95E2EA Q36028581-96E511D9-33B7-4C0F-B101-4D267BA55BA1 Q36047248-077E7447-7D21-48E8-9D69-24599A7F283F Q36593828-A9EFFE1E-6276-4A31-AA33-DF59550DC85E Q39143538-3B0A6F05-B6E1-4A4B-8A09-281E70E6A2FA Q39472017-B228415B-6066-416F-A12B-6520C744C149 Q39473366-1966539A-7FFF-4A9E-8196-0175DD8CC9F8 Q39478343-4CC93A22-B431-4451-AACB-1F5DEF30446F Q39519447-EE928514-2883-4328-99FB-52CC2335393E Q39682438-6259AD98-133D-40A5-93C3-E460AEF69083 Q39743472-6F1AA77D-C1AE-4646-BA18-F61913FEAE8A Q39743528-9935363F-BC41-409E-A834-124D4A292DFD Q39954579-DD6EC646-1ED3-472A-BBFE-7796341970CE Q40130546-6373E5C1-04D4-4BBF-98BF-D77480FDC0F4 Q42112160-10EBFBE9-6C54-4F98-9C6F-0BE818652376 Q42653919-BC01D34C-D69A-4BD1-87A8-79758EA136A7 Q42730587-3BDB0251-3404-49F3-9CDA-32D00EFA8EC2 Q43063844-C809F016-0A44-412D-A3D9-6AF3FFF802AD Q43069250-4D64A080-667C-4CC0-8A51-68BDD1366008

P2860

Fluoroquinolone resistance mutations in the parC, parE, and gyrA genes of clinical isolates of viridans group streptococci

http://www.wikidata.org/entity/Q33700561

description

1998 nî lūn-bûn

@nan

1998 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

1998 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

1998年の論文

@ja

1998年論文

@yue

1998年論文

@zh-hant

1998年論文

@zh-hk

1998年論文

@zh-mo

1998年論文

@zh-tw

1998年论文

@wuu

name

Fluoroquinolone resistance mut ...... of viridans group streptococci

@ast

Fluoroquinolone resistance mut ...... of viridans group streptococci

@en

type

label

Fluoroquinolone resistance mut ...... of viridans group streptococci

@ast

Fluoroquinolone resistance mut ...... of viridans group streptococci

@en

prefLabel

Fluoroquinolone resistance mut ...... of viridans group streptococci

@ast

Fluoroquinolone resistance mut ...... of viridans group streptococci

@en

P1433

Q33700561-929B8ED7-7243-4DD8-AFE1-5C7DE040ECF4

P1476

Q33700561-B5C5896F-1D6E-4C38-9AA8-93FCE3514945

P2093

Q33700561-5BBCB62F-FA4A-4E63-A7D0-9E5CF36DDAD5

Q33700561-B55ACDBC-CB08-4083-BB7D-A0EB224464F2

Q33700561-C7D9D0D5-8BA8-4644-AE3C-052D29F4B49A

Q33700561-FEE6EF9B-097B-43EF-8A74-C9DEDCFECE64

P2860

Q33700561-03FF2606-57EA-49E7-8D8C-16C6723B6057

Q33700561-04FB74D2-F452-4EB2-B6D6-3351DC6DAC5D

Q33700561-079D288A-3E09-4672-8C55-AA41D284A399

Q33700561-0D2C76F3-D38E-47F2-99C6-877D7C0CD986

Q33700561-1395E4B2-D8E0-4970-97E9-2D7993487EA2

Q33700561-188EF2F1-E5B1-4267-8A08-196DA9758790

Q33700561-252ABE2F-8713-4030-90BC-A33F61DD6032

Q33700561-2AD63BD4-1044-4E74-93B8-93BCD47F5C9A

Q33700561-3343A33A-1D0C-435B-B4FE-9CEA67134171

Q33700561-4049C45C-F0A8-48B3-8693-03735846BD13

P304

Q33700561-D2DA55C3-67B0-4D45-A480-559ED1E9DD2F

P31

Q33700561-0F3EC393-EB42-4932-9A8E-95F79D454E9E

P356

Q33700561-88757F89-361C-49FB-823A-4AB1B9F687E8

P407

Q33700561-1AA4C3F5-97CD-4F67-A388-DC56B4219908

P433

Q33700561-37B18768-9390-4FC3-9ADC-802A1E7A8884

P478

Q33700561-99A892D5-7D26-4ABC-AF2F-5622BDCCA54C

P50

Q33700561-5B2C7C34-40B8-404F-9A09-75FFE162D252

Q33700561-B8DB53C7-46D1-46E9-9737-C130DE83250A

P577

Q33700561-E2D27FFF-8CC8-4966-A2E1-6EB494EB8741

P698

Q33700561-BB83BDA2-8ED4-4C95-8B63-C4BBD5D586D3

P932

Q33700561-73E9E120-FAE2-474D-988C-4AA6DB7A057C

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Fluoroquinolone resistance mut ...... of viridans group streptococci

@en

P2093

Balas D

http://www.w3.org/2001/XMLSchema#string

Georgiou M

http://www.w3.org/2001/XMLSchema#string

González I

http://www.w3.org/2001/XMLSchema#string

Liñares J

http://www.w3.org/2001/XMLSchema#string

P2860

Topoisomerase IV is a target of quinolones in Escherichia coli

Analysis by PCR and direct DNA sequencing of gyrA mutations associated with fluoroquinolone resistance in Enterococcus faecalis.

Resistance to antibiotics mediated by target alterations.

In vitro activities of 22 beta-lactam antibiotics against penicillin-resistant and penicillin-susceptible viridans group streptococci isolated from blood.

Ciprofloxacin-resistant Haemophilus influenzae strains possess mutations in analogous positions of GyrA and ParC.

In vitro activities of eight macrolide antibiotics and RP-59500 (quinupristin-dalfopristin) against viridans group streptococci isolated from blood of neutropenic cancer patients.

Contribution of mutations in gyrA and parC genes to fluoroquinolone resistance of mutants of Streptococcus pneumoniae obtained in vivo and in vitro.

High-level fluoroquinolone resistance in Streptococcus pneumoniae requires mutations in parC and gyrA.

Quinolone resistance locus nfxD of Escherichia coli is a mutant allele of the parE gene encoding a subunit of topoisomerase IV.

Characterization of a mutation in the parE gene that confers fluoroquinolone resistance in Streptococcus pneumoniae

P304

2792-2798

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.42.11.2792

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

42

http://www.w3.org/2001/XMLSchema#string

P50

Fernando Alcaide

A G de la Campa

P577

1998-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9797205

http://www.w3.org/2001/XMLSchema#string

P932

105945

http://www.w3.org/2001/XMLSchema#string